
|Articles|April 28, 2003
FDA-approved catheter enhances BPH procedure
Urologix, Inc. has received FDA approval to market the Cooled ThermoCathtreatment catheter, which is designed for use in conjunction with the company'sTargis microwave generator, for the treatment of BPH. The product incorporatescatheter cooling technology designed to improve the heat exchange coupledwith improved catheter conformance to urethral tissue.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5








